CDK Global (CDK) Tops Q1 EPS by 3c

CDK Global (NASDAQ: CDK) reported Q1 EPS of $0.37, $0.03 better than the analyst estimate of $0.34. Revenue for the quarter came in at $514.6 million versus the consensus estimate of $506.38 million.

The fiscal 2016 growth forecasts that follow are based on fiscal 2015 results adjusted for certain non-GAAP items for comparability to fiscal 2016 as shown in our fiscal 2015 year-end earnings press release and presented at the end of this release. On this adjusted basis, the forecast that follows is unchanged:

• Adjusted revenues – we anticipate 4% to 5% growth from $2,017.3 million in fiscal 2015
• Adjusted earnings before income taxes – we anticipate at least 25% growth from the adjusted $333.3 million in fiscal 2015
• Adjusted pretax margin – we anticipate at least 300 basis points of expansion from the adjusted 16.5% in fiscal 2015
• Adjusted EBITDA margin – we anticipate at least 300 basis points of expansion from the adjusted 22.9% in fiscal 2015
• Adjusted net earnings attributable to CDK – we anticipate over 25% growth from the adjusted $210.5 million in fiscal 2015
• Adjusted diluted net earnings attributable to CDK per share – we anticipate over 25% growth from the adjusted $1.30 in fiscal 2015

For earnings history and earnings-related data on CDK Global (CDK) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
• Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c